Literature DB >> 23879563

Prevalence of hepatitis B and hepatitis D coinfection in asymptomatic blood donors in Iran.

Mona Seyed Attaran1, Zohreh Sharifi, Seyed Masoud Hosseini, Shahram Samei, Zahrah Ataee.   

Abstract

Hepatitis delta virus (HDV) is a satellite virus that needs hepatitis B virus (HBV) surface antigen for amplification and transition. HDV appears in HBsAg carriers as acute coinfection and superinfection in patients with chronic hepatitis B. This coinfection leads to chronic hepatitis, cirrhosis, and liver carcinoma. The aim of this study was to detect the prevalence of coinfection and superinfection of HBVs and HDVs in blood donor individuals in Iran. Sera from 854 asymptomatic blood donors from the Bank of positive samples storage at the National Blood Transfusion Organization of Iran that were positive for hepatitis B surface antigen were analysed. The presence of antibody against HDV in blood donors was detected using ELISA followed by conventional PCR, seminested PCR and real-time PCR to determine coinfection and/or superinfection. Restriction fragment length polymorphism was used for HDV genotyping. All 854 samples were HBsAg and anti-HBc positive whereas only 18 (2%) of them were positive for anti-HDV. Of the 854 samples, 154 (18%) were HBV-DNA positive. HDV-RNA was detected in 0.6% of the total samples by seminested PCR and real-time PCR and the two PCR methods produced similar results. Moreover, 16.6% and 83.4% of anti-HDV-positive samples exhibited coinfection and superinfection with HBV, respectively. Genotype I of HDV was determined in positive samples.
© 2013 APMIS. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Hepatitis delta virus; Iran; RFLP; coinfection; hepatitis B virus

Mesh:

Substances:

Year:  2013        PMID: 23879563     DOI: 10.1111/apm.12137

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  5 in total

1.  The Prevalence and Risk Factors of Hepatitis Delta Virus in HIV/HBV Co-Infected Patients in Shiraz, Iran, 2012.

Authors:  Mohammad Motamedifar; Mohammad Taheri; Kamran Bagheri Lankarani; Mina Gholami; Mahmood Amini Lari; Hossein Faramarzi; Jamal Sarvari
Journal:  Iran J Med Sci       Date:  2015-09

2.  Prevalence of hepatitis D virus in hepatitis B virus infected patients referred to Taleghani hospital, Tehran, Iran.

Authors:  Seyed Mohammad Ebrahim Tahaei; Seyed Reza Mohebbi; Pedram Azimzadeh; Abbas Behelgardi; Azar Sanati; Parvaneh Mohammadi; Mahsa Khanyaghma; Armin Hosseini Razavi; Afsaneh Sharifian; Mohammad Reza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2014

3.  A population based study on hepatitis B virus in northern iran, amol.

Authors:  Hossein Keyvani; Masoudreza Sohrabi; Farhad Zamani; Hossein Poustchi; Hossein Ashrafi; Fatemeh Saeedian; Mansooreh Mooadi; Nima Motamed; Hossein Ajdarkosh; Mahmoodreza Khonsari; Gholamreza Hemmasi; Mitra Ameli; Ali Kabir; Mahmoud Khodadost
Journal:  Hepat Mon       Date:  2014-08-17       Impact factor: 0.660

4.  Hepatitis D virus infection in Kermanshah, west of Iran: seroprevalence and viremic infections.

Authors:  Babak Sayad; Yosra Naderi; Seyed Moayed Alavian; Farid Najafi; Alireza Janbakhsh; Feyzollah Mansouri; Siavash Vaziri; Mandana Afsharian; Fatemeh Norooznezhad
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2018

5.  Serological and molecular characterization of hepatitis B virus in asymptomatic blood donors in Iran.

Authors:  Mona Seyed Attaran; Seyed Masoud Hosseini; Javad Fakhari; Zohreh Sharifi
Journal:  Iran J Microbiol       Date:  2018-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.